Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avery D Posey

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Molecular Therapy. Oncology|March 2, 2026
CD2 costimulation breaks the CD28 vs. 4-1BB tradeoff in CAR T cellsAvery D Posey
Nature Immunology|November 27, 2023
Forks in the road for CAR T and CAR NK cell cancer therapiesOula K Dagher, Avery D Posey
Cell Stem Cell|April 5, 2024
Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunityHeather M Sosnoski, Avery D Posey
Cells|December 24, 2021
Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular ImmunityJohn T Keane, Avery D Posey
Cancer Journal (Sudbury, Mass.)|January 24, 2023
Chimeric Antigen Receptor T-Cell Therapy: Current Perspective on T Cell-Intrinsic, T Cell-Extrinsic, and Therapeutic LimitationsShawna K Brookens, Avery D Posey
Nature Cancer|February 5, 2022
Splitting signals drives CARs furtherTiffany R King-Peoples, Avery D Posey
ILAR Journal|May 17, 2019
Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell DevelopmentDenis Migliorini, Nicola J Mason, Avery D Posey
Immunity|November 17, 2016
Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to SafetyAvery D Posey, Henrik Clausen, Carl H June
Current Topics in Developmental Biology|May 31, 2011
Ferlin proteins in myoblast fusion and muscle growthAvery D Posey, Alexis Demonbreun, Elizabeth M McNally
Trends in Cancer|June 9, 2024
Future perspectives on engineered T cells for cancerAvery D Posey, Regina M Young, Carl H June
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Molecular Therapy. Oncology|March 2, 2026
CD2 costimulation breaks the CD28 vs. 4-1BB tradeoff in CAR T cellsAvery D Posey
Nature Immunology|November 27, 2023
Forks in the road for CAR T and CAR NK cell cancer therapiesOula K Dagher, Avery D Posey
Cell Stem Cell|April 5, 2024
Therapeutic intersections: Expanding benefits of CD19 CAR T cells from cancer to autoimmunityHeather M Sosnoski, Avery D Posey
Cells|December 24, 2021
Chimeric Antigen Receptors Expand the Repertoire of Antigenic Macromolecules for Cellular ImmunityJohn T Keane, Avery D Posey
Cancer Journal (Sudbury, Mass.)|January 24, 2023
Chimeric Antigen Receptor T-Cell Therapy: Current Perspective on T Cell-Intrinsic, T Cell-Extrinsic, and Therapeutic LimitationsShawna K Brookens, Avery D Posey
Nature Cancer|February 5, 2022
Splitting signals drives CARs furtherTiffany R King-Peoples, Avery D Posey
ILAR Journal|May 17, 2019
Keeping the Engine Running: The Relevance and Predictive Value of Preclinical Models for CAR-T Cell DevelopmentDenis Migliorini, Nicola J Mason, Avery D Posey
Immunity|November 17, 2016
Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to SafetyAvery D Posey, Henrik Clausen, Carl H June
Current Topics in Developmental Biology|May 31, 2011
Ferlin proteins in myoblast fusion and muscle growthAvery D Posey, Alexis Demonbreun, Elizabeth M McNally
Trends in Cancer|June 9, 2024
Future perspectives on engineered T cells for cancerAvery D Posey, Regina M Young, Carl H June
Pageof 6